Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Tonghua Dongbao Pharmaceutical Co Ltd Receives GMP Permit in European Union


Tuesday, 23 Jul 2013 08:00pm EDT 

Tonghua Dongbao Pharmaceutical Co Ltd announced that it has received Good Manufacturing Practice (GMP) permit on July 23, 2013 (No. 24: 2012/514130) from the European Union. The permit is with a valid period of three years. The permit is for the Company's recombination human insulinum bulk pharmaceutical chemicals workshop. 

Company Quote

13.24
-0.17 -1.27%
2:59am EDT